Bronchiolitis, Viral
Bronchiolitis Obliterans
Cryptogenic Organizing Pneumonia
Lung Transplantation
Respiratory Syncytial Virus Infections
Respiratory Syncytial Viruses
Respiratory Syncytial Virus, Human
Bronchopneumonia
Respiratory Sounds
Respirovirus Infections
Lung
Collagen Type V
Transplantation, Heterotopic
Bronchodilator Agents
Respiratory Function Tests
Heart-Lung Transplantation
Metapneumovirus
Bronchoalveolar Lavage Fluid
Nebulizers and Vaporizers
Croup
Graft Rejection
Respiratory Aspiration
Oxygen Inhalation Therapy
Paramyxoviridae Infections
Bronchitis
Helium
Respiratory Tract Infections
Bronchi
Trachea
Nasopharynx
Saline Solution, Hypertonic
Guadeloupe
Administration, Inhalation
Biopsy
Bronchioles
Lung Diseases, Interstitial
Albuterol
Bronchoalveolar Lavage
Respiratory Rate
Nasal Lavage Fluid
Mediastinal Emphysema
Severity of Illness Index
Azithromycin
Asthma
Transplantation, Homologous
Respiratory Therapy
Intensive Care Units, Pediatric
Follow-Up Studies
Prednisolone
Retrospective Studies
Radiography, Thoracic
Glucocorticoids
Respiration, Artificial
Pulmonary Fibrosis
Eosinophil Cationic Protein
Prospective Studies
Forced Expiratory Volume
A new model rat with acute bronchiolitis and its application to research on the toxicology of inhaled particulate matter. (1/342)
The aim of the present study was to establish a useful animal model that simulates humans sensitive to inhaled particulate matter (PM). We have developed a new rat model of acute bronchiolitis (Br) by exposing animals to NiCl2 (Ni) aerosols for five days. Three days following the Ni exposure, the animals developed signs of tachypnea, mucous hypersecretion, and bronchiolar inflammation which seemed to progress quickly during the fourth to fifth day. They recovered from lesions after four weeks in clean air. To assess the sensitivity of the Br rats to inhaled particles, two kinds of PM of respirable size were tested with doses similar to or a little higher to the recommended threshold limit values (TLVs) for the working environment in Japan. Titanium dioxide (TiO2 = Ti) was chosen as an inert and insoluble particles and vanadium pentoxide (V2O5 = V), as a representative soluble and toxic airborne material. The Br rats exposed to either Ti or V were compared the pathological changes in the lungs and the clearance of particles to those in normal control or Br rats kept in clean air. The following significant differences were observed in Br rats: 1. delayed recovery from pre-existing lesions or exacerbated inflammation, 2. reductions in deposition and clearance rate of inhaled particles with the progress of lesions. The present results suggest that Br rats are more susceptible to inhaled particles than control rats. Therefore, concentrations of particulate matter lower than the TLVs for Japan, which have no harmful effects on normal lungs, may not always be safe in the case of pre-existing lung inflammation. (+info)Seroprevalence of IgG antibodies to the chlamydia-like microorganism 'Simkania Z' by ELISA. (2/342)
The newly described microorganism 'Simkania Z', related to the Chlamydiae, has been shown to be associated with bronchiolitis in infants and community acquired pneumonia in adults. The prevalence of infection in the general population is unknown. A simple ELISA assay for the detection of serum IgG antibodies to 'Simkania Z' was used to determine the prevalence of such antibodies in several population samples in southern Israel (the Negev). The groups tested included 94 medical and nursing students, 100 unselected blood donors, 106 adult members of a Negev kibbutz (communal agricultural settlement), and 45 adult Bedouin, residents of the Negev. IgG antibodies to 'Simkania Z' were found in 55-80% of these presumably healthy individuals, independently of antibodies to Chlamydia trachomatis and Chlamydia pneumoniae. The Bedouin had a seropositivity rate of 80%, while all other groups had rates of between 55 and 64%. These results indicate that 'Simkania Z' infection is probably common in southern Israel. (+info)Pathological and radiological changes in resected lung specimens in Mycobacterium avium intracellulare complex disease. (3/342)
The present study was designed to evaluate the pathological and immunohistochemical findings of Mycobacterium avium intracellulare complex (MAC) lung infection. A retrospective study was performed in five cases with positive cultures for MAC in whom lung resections were performed between January 1989 and December 1996. A determination of whether or not MAC caused pulmonary disease was made using the 1997 criteria defined by the American Thoracic Society. In addition, MAC was cultured from all of the five lung specimens. Pathological and immunohistochemical findings as well as chest computed tomography (CT) findings were evaluated in these five patients. Pathological findings of bronchiectasis, bronchiolitis, centrilobular lesion, consolidation, cavity wall and nodules were demonstrated, respectively, in relation to chest CT findings. Extensive granuloma formation throughout the airways was clearly demonstrated. Immunohistochemical staining demonstrated: 1) epithelioid cells and giant cells; 2) myofibroblasts extensively infiltrating the cavity wall; and 3) B-cells detected in aggregates in the vicinity of the epithelioid granulomas. This study identified pathological and immunohistochemical characteristics of Mycobacterium avium complex infection relative to chest computed tomography findings and allowed the conclusion that bronchiectasis and bronchiolitis were definitely caused by Mycobacterium avium complex infection. (+info)Antineutrophil cytoplasmic antibodies in diffuse panbronchiolitis. (4/342)
BACKGROUND: There are some reports of the coexistence of chronic suppurative lung diseases such as cystic fibrosis and systemic vasculitis. Diffuse panbronchiolitis has the same characteristics as chronic recurrent sinopulmonary infection and respiratory bronchiolitis. METHODS: Serum samples from 30 patients with diffuse panbronchiolitis and 57 patients with other pulmonary diseases were tested to find the titer of myeloperoxidase antineutrophil cytoplasmic antibodies (MPO-ANCA). RESULTS: We found MPO-ANCA positivity in 4 patients with diffuse panbronchiolitis but not in those with other pulmonary diseases. CONCLUSIONS: Our findings show that MPO-ANCA is positive in some patients with diffuse panbronchiolitis. Careful attention should be paid to the combination of chronic pulmonary infection and various vasculitis. (+info)Clinical and immunoregulatory effects of roxithromycin therapy for chronic respiratory tract infection. (5/342)
The clinical and immunoregulatory effects of long-term macrolide antibiotic therapy for patients with chronic lower respiratory tract infections (CLRTI) were investigated. Clinical parameters and neutrophil chemotactic mediators in the epithelial lining fluid (ELF) of CLRTI patients (n = 10) were examined before and after 3 months oral administration of roxithromycin (RXM). The in vitro effects of RXM were also examined on the release of these mediators from alveolar macrophages (AM) and neutrophils. Arterial oxygen tension (p<0.05), vital capacity (VC) (p<0.001), %VC (p<0.05) and forced expiratory volume in one second (p<0.01) were improved after RXM treatment, but airway bacteria were not eradicated. Among the mediators, the levels of interleukin (IL)-8, neutrophil elastase (NE) and leukotriene B4 (LTB4) were higher in ELF than in plasma of CLRTI patients and they decreased after RXM treatment (n = 7, p<0.05 for each). RXM concentrations were significantly increased in the bronchoalveolar lavage cells of the treated patients. In in vitro experiments, RXM showed inhibitory effects on IL-8 release from AM and neutrophils. In conclusion, interleukin-8, neutrophil elastase and leukotriene B4 contribute to the neutrophilic inflammation in the airways of chronic lower respiratory tract infection patients and the clinical effects of roxithromycin may, in part, be attributable to the suppression of excess release of the chemotactic mediators from inflammatory cells. (+info)Clinical significance of respiratory bronchiolitis on open lung biopsy and its relationship to smoking related interstitial lung disease. (6/342)
BACKGROUND: Respiratory bronchiolitis-associated interstitial lung disease (RBILD) is a rare form of interstitial lung disease which may present in similar fashion to other types of chronic interstitial pneumonia. The purpose of this study was to undertake a clinicopathological review of 10 patients with RBILD and to examine the clinical and imaging data related to its histopathological pattern, in particular the relationship of RBILD to smoking. METHODS: Thirteen out of 168 retrospectively reviewed patients, from whom biopsy specimens were taken for suspected diffuse lung disease, were identified with a histopathological pattern of RBILD. Three cases were rejected as follow up data were unavailable. The 10 remaining cases constituted the study group and both clinical and imaging data were collected from patients' notes and referring physicians. RESULTS: Histopathologically, four cases of RBILD overlapped with the pattern of desquamative interstitial pneumonitis (DIP) and nine also had microscopic evidence of centrilobular emphysema. Nine patients were smokers, ranging from 3 to 80 pack years. The one non-smoker had an occupational exposure to the fumes of solder flux. The sex distribution was equal with an age range of 32-65 years. Two patients were clubbed. Lung function tests showed both restrictive and obstructive patterns together with severe reductions in carbon monoxide transfer factor in seven patients. Chest radiographs showed reticular or reticulonodular infiltrates in five patients and a ground glass pattern in two. CT scans were consistent with either DIP or RBILD in six of eight patients. Although seven patients remained stable or improved, either with or without treatment, three patients deteriorated. CONCLUSIONS: This study adds weight to the hypothesis that smoking can cause clinically significant interstitial lung disease, with deterioration in pulmonary function despite treatment. Given the overlapping histopathological patterns of RBILD and DIP and their strong association with smoking, the term "smoking related interstitial lung disease" is suggested for those patients who are smokers. (+info)Bronchiolitis in Kartagener's syndrome. (7/342)
The association of diffuse bronchiolitis in patients with Kartagener's syndrome (KS) has not been reported previously. The aim of this study was to present the morphological characteristics of bronchiolitis in patients with KS. Eight patients (four males, four females; mean age 37.9+/-18.7 yrs), clinically diagnosed as KS with the classical triad of chronic pansinusitis, bronchiectasis and situs in versus with dextrocardia, were evaluated. Routine chest radiography showed bronchiectasis and dextrocardia in all patients. Chest computed tomography (CT) showed diffuse centrilobular small nodules up to 2 mm in diameter throughout both lungs in six out of eight patients. Pulmonary function tests revealed marked obstructive impairment in all patients (forced expiratory volume in one second 57.0+/-11.3%, residual volume/total lung capacity 45.+/-12.7%, maximum midexpiratory flow 0.92+/-0.72 L x s(-1), forced vital capacity 74.1+/-12.2% (all mean +/- SD)). The examination of cilial movement of the bronchus revealed immotility in all of the five patients examined. The ultrastructure showed ciliary dynein arm defects in all patients. Histopathological examination of lung specimens obtained at autopsy or by video-assisted thoracoscopic surgery showed obliterative thickening of the walls of the membranous bronchioli with infiltration of lymphocytes, plasma cells and neutrophils, but most of the distal respiratory bronchioli were spared and alveolar spaces were overinflated. Pathologically, the diffuse centrilobular small nodules on the chest CT mainly corresponded to membranous bronchiolitis. This is the first report demonstrating that the association of diffuse bronchiolitis might be one of the characteristic features of the lung in Kartagener's syndrome. (+info)Respiratory syncytial virus infection and G and/or SH protein expression contribute to substance P, which mediates inflammation and enhanced pulmonary disease in BALB/c mice. (8/342)
A distinct clinical presentation of respiratory syncytial virus (RSV) infection of humans is bronchiolitis, which has clinical features similar to those of asthma. Substance P (SP), a tachykinin neuropeptide, has been associated with neurogenic inflammation and asthma; therefore, we chose to examine SP-induced inflammation with RSV infection. In this study, we examined the production of pulmonary SP associated with RSV infection of BALB/c mice and the effect of anti-SP F(ab)(2) antibodies on the pulmonary inflammatory response. The peak production of pulmonary SP occurred between days 3 and 5 following primary RSV infection and day 1 after secondary infection. Treatment of RSV-infected mice with anti-SP F(ab)(2) antibodies suggested that SP may alter the natural killer cell response to primary and secondary infection. In mice challenged after formalin-inactivated RSV vaccination, SP appears to markedly enhance pulmonary eosinophilia as well as increase polymorphonuclear cell trafficking to the lung. Based on studies with a strain of RSV that lacks the G and SH genes, the SP response to RSV infection appears to be associated with G and/or SH protein expression. These data suggest that SP may be an important contributor to the inflammatory response to RSV infection and that anti-SP F(ab)(2) antibodies might be used to ameliorate RSV-associated disease. (+info)Terms related to Bronchiolitis:
* Acute bronchiolitis: This is a sudden and severe form of bronchiolitis that typically lasts for a few days.
* Chronic bronchiolitis: This is a long-term condition characterized by persistent inflammation and narrowing of the airways.
* Asthmatic bronchiolitis: This is a type of bronchiolitis that is associated with asthma.
Synonyms for Bronchiolitis:
* Bronchitis
* Pneumonia
* Respiratory syncytial virus (RSV) infection
Antonyms for Bronchiolitis:
* None
Hypernyms for Bronchiolitis:
* Respiratory disease
* Infectious disease
Hypersonyms for Bronchiolitis:
* Acute bronchiolitis
* Chronic bronchiolitis
* Asthmatic bronchiolitis
Collocations for Bronchiolitis:
* Viral bronchiolitis
* Bacterial bronchiolitis
* Allergic bronchiolitis
Idiomatic expressions related to Bronchiolitis:
* "Bronchiolitis attack"
* "Bronchiolitis episode"
* "Bronchiolitis flare-up"
Phrases that include Bronchiolitis:
* "Bronchiolitis diagnosis"
* "Bronchiolitis treatment"
* "Bronchiolitis management"
Other words that are related to Bronchiolitis but not included in the list above:
* Mucus
* Cough
* Wheezing
* Shortness of breath
* Chest tightness
* Fever
* Runny nose
Note: Some of these words may have multiple meanings or be used in different contexts, but they are all related to Bronchiolitis in some way.
The diagnosis is typically made based on clinical examination and medical history. Chest X-rays or blood tests may be ordered to confirm the diagnosis and rule out other conditions. Treatment involves supportive care, such as oxygen therapy, hydration, and medications to relieve coughing and wheezing. Antiviral medications may be prescribed in severe cases.
Complications of viral bronchiolitis include pneumonia, respiratory failure, and asthma. In rare cases, the virus can spread to the brain and cause encephalitis or meningitis. Prevention involves good hygiene practices, such as frequent handwashing, avoiding close contact with people who are sick, and not sharing utensils or personal items.
Viral bronchiolitis is usually caused by a member of the picornavirus family, such as the respiratory syncytial virus (RSV) or human metapneumovirus (HMPV). These viruses are highly contagious and can be spread through contact with an infected person's respiratory secretions. The incubation period is typically 2-5 days, and the disease is most commonly seen in the winter months when the virus is more prevalent.
The management of viral bronchiolitis requires a multidisciplinary approach, involving primary care physicians, pediatricians, infectious disease specialists, and respiratory therapists. Early recognition and treatment can help reduce the risk of complications and improve outcomes for patients.
The exact cause of Bronchiolitis Obliterans is not fully understood, but it is believed to be due to a combination of genetic and environmental factors. The condition is often associated with allergies and asthma, and viral infections such as respiratory syncytial virus (RSV) can trigger the onset of symptoms.
Symptoms of Bronchiolitis Obliterans include:
* Persistent coughing, which may be worse at night
* Shortness of breath or wheezing
* Chest tightness or discomfort
* Fatigue and poor appetite
* Recurrent respiratory infections
BO is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or pulmonary function tests. There is no cure for Bronchiolitis Obliterans, but treatment options are available to manage symptoms and slow the progression of the disease. These may include:
* Medications such as bronchodilators and corticosteroids to reduce inflammation and improve lung function
* Pulmonary rehabilitation programs to improve breathing and overall health
* Oxygen therapy to help increase oxygen levels in the blood
* In severe cases, lung transplantation may be considered.
While Bronchiolitis Obliterans can significantly impact quality of life, with proper management and care, many individuals with the condition are able to lead active and productive lives.
COP typically affects middle-aged adults and is more common in women than men. Symptoms include cough, shortness of breath, fever, and fatigue. The condition can be acute or chronic, and it can lead to respiratory failure if left untreated.
The exact cause of COP is not known, but it is believed to be related to an abnormal immune response to environmental triggers, such as cigarette smoke or other inhaled substances. The disease is often associated with other autoimmune disorders, such as rheumatoid arthritis or lupus.
Diagnosis of COP is based on a combination of clinical findings, radiologic imaging (such as chest x-rays and CT scans), and lung biopsy. Treatment typically involves corticosteroids to reduce inflammation and improve lung function. In severe cases, respiratory support may be necessary.
The prognosis for COP varies depending on the severity of the disease and the response to treatment. In general, the condition can be managed with appropriate therapy, but it can be challenging to diagnose and treat effectively.
RSV infections can cause a range of symptoms, including:
* Runny nose
* Decreased appetite
* Coughing
* Sneezing
* Wheezing
* Apnea (pauses in breathing)
* Blue-tinged skin and lips (cyanosis)
* Fever
* Inflammation of the lower respiratory tract (bronchiolitis)
* Pneumonia
In severe cases, RSV infections can lead to hospitalization and may require oxygen therapy or mechanical ventilation. In rare cases, RSV infections can be life-threatening, particularly in premature babies and infants with underlying medical conditions.
There is no specific treatment for RSV infections, but antiviral medications may be prescribed in severe cases. Treatment focuses on relieving symptoms and managing the infection, such as providing hydration and nutrition, administering oxygen therapy, and monitoring vital signs.
Prevention measures for RSV infections include:
* Frequent handwashing, especially after contact with an infected person or their secretions
* Avoiding close contact with anyone who has RSV infection
* Keeping children home from school or daycare if they are showing symptoms of RSV infection
* Practicing good hygiene, such as avoiding sharing utensils or personal items with anyone who is infected
There is currently no vaccine available to protect against RSV infections, but researchers are working on developing one.
Bronchopneumonia is a serious condition that can lead to respiratory failure and other complications if left untreated. It is important for individuals with bronchopneumonia to seek medical attention promptly if they experience any worsening symptoms or signs of infection, such as increased fever or difficulty breathing.
Bronchopneumonia can be caused by a variety of factors, including bacterial and viral infections, and can affect individuals of all ages. It is most common in young children and the elderly, as well as those with pre-existing respiratory conditions such as asthma or chronic obstructive pulmonary disease (COPD).
Treatment for bronchopneumonia typically involves antibiotics to treat any bacterial infections, as well as supportive care to help manage symptoms and improve lung function. In severe cases, hospitalization may be necessary to provide more intensive treatment and monitoring.
In addition to antibiotics and supportive care, other treatments for bronchopneumonia may include:
* Oxygen therapy to help increase oxygen levels in the blood
* Pain management medications to relieve chest pain and fever
* Breathing exercises and pulmonary rehabilitation to improve lung function
* Rest and relaxation to help the body recover
Prevention is key in avoiding bronchopneumonia, and this can be achieved through:
* Good hand hygiene and respiratory etiquette
* Avoiding close contact with individuals who are sick
* Getting vaccinated against pneumococcal disease and the flu
* Practicing good hygiene during travel to avoid exposure to respiratory infections.
In conclusion, bronchopneumonia is a serious condition that can be caused by a variety of factors and can affect individuals of all ages. Treatment typically involves antibiotics and supportive care, and prevention strategies include good hygiene practices and vaccination. With proper treatment and care, individuals with bronchopneumonia can recover and lead active lives.
Clinical Significance:
Respiratory sounds can help healthcare providers diagnose and manage respiratory conditions, such as asthma, chronic obstructive pulmonary disease (COPD), and pneumonia. By listening to the sounds of a patient's breathing, healthcare providers can identify abnormalities in lung function, airway obstruction, or inflammation.
Types of Respiratory Sounds:
1. Vesicular Sounds:
a. Inspiratory wheeze: A high-pitched whistling sound heard during inspiration, usually indicative of bronchial asthma or COPD.
b. Expiratory wheeze: A low-pitched whistling sound heard during expiration, typically seen in patients with chronic bronchitis or emphysema.
c. Decreased vocal fremitus: A decrease in the normal vibratory sounds heard over the lung fields during breathing, which can indicate fluid or consolidation in the lungs.
2. Adventitious Sounds:
a. Crackles (rales): High-pitched, bubbly sounds heard during inspiration and expiration, indicating fluid or air in the alveoli.
b. Rhonchi: Low-pitched, harsh sounds heard during inspiration and expiration, often indicative of bronchitis, pneumonia, or COPD.
c. Stridors: High-pitched, squeaky sounds heard during breathing, commonly seen in patients with inflammatory conditions such as pneumonia or tuberculosis.
It's important to note that the interpretation of lung sounds requires a thorough understanding of respiratory physiology and pathophysiology, as well as clinical experience and expertise. A healthcare professional, such as a nurse or respiratory therapist, should always be consulted for an accurate diagnosis and treatment plan.
Respirovirus infections are a group of viral infections that affect the respiratory system, including the nose, throat, and lungs. These infections are caused by members of the Paramyxoviridae family of viruses, which include the respiratory syncytial virus (RSV), human metapneumovirus (HMPV), and human parainfluenza virus (HPIV).
The symptoms of respirovirus infections can vary depending on the age of the individual and the severity of the infection. In infants and young children, the symptoms may include coughing, sneezing, runny nose, fever, and difficulty breathing. In older children and adults, the symptoms may be more mild and may include a stuffy nose, sore throat, and cough.
Respirovirus infections are usually spread through contact with an infected person's respiratory secretions, such as mucus and saliva. The viruses can also survive on surfaces for a period of time and be transmitted through touching contaminated surfaces and then touching the face.
There is no specific treatment for respirovirus infections, but antiviral medications may be prescribed in severe cases. Treatment is generally focused on relieving symptoms and managing complications, such as pneumonia or bronchiolitis. In some cases, hospitalization may be necessary to provide supportive care, such as oxygen therapy and mechanical ventilation.
Prevention of respirovirus infections is important, especially for high-risk individuals such as infants, young children, and people with weakened immune systems. Preventative measures include frequent handwashing, avoiding close contact with people who are sick, and practicing good hygiene. Vaccines are also available for some types of respirovirus infections, such as RSV, and can help protect against infection.
Examples of acute diseases include:
1. Common cold and flu
2. Pneumonia and bronchitis
3. Appendicitis and other abdominal emergencies
4. Heart attacks and strokes
5. Asthma attacks and allergic reactions
6. Skin infections and cellulitis
7. Urinary tract infections
8. Sinusitis and meningitis
9. Gastroenteritis and food poisoning
10. Sprains, strains, and fractures.
Acute diseases can be treated effectively with antibiotics, medications, or other therapies. However, if left untreated, they can lead to chronic conditions or complications that may require long-term care. Therefore, it is important to seek medical attention promptly if symptoms persist or worsen over time.
Previous Article The Importance of Self-Care for Physicians
Next Article How Technology is Revolutionizing Healthcare: Top 5 Trends
A type of pneumonia caused by a viral infection. The most common viruses that cause pneumonia are the respiratory syncytial virus (RSV), influenza virus, and adenovirus.
Symptoms include fever, cough, chest pain, difficulty breathing, and loss of appetite.
Treatment typically involves antiviral medications and supportive care to manage symptoms and improve lung function. In severe cases, hospitalization may be necessary.
Prevention measures include vaccination against the flu and RSV, good hygiene practices such as frequent handwashing, and avoiding close contact with people who are sick.
Respiratory aspiration can lead to a range of complications, including pneumonia, bronchitis, and lung abscesses. It can also cause respiratory failure, which can be life-threatening.
Symptoms of respiratory aspiration may include coughing, wheezing, difficulty breathing, and fever. Diagnosis is typically made through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or endoscopy. Treatment may involve antibiotics for any infections that have developed, as well as supportive care to help the individual breathe more easily. In severe cases, respiratory aspiration may require hospitalization and mechanical ventilation.
Preventing respiratory aspiration is important, especially for individuals who are at high risk. This can involve modifications to their diet, such as thickening liquids or pureeing foods, as well as using specialized feeding tubes or devices that help to prevent the entry of foreign substances into the respiratory tract.
* Parainfluenza: This is a group of viruses that cause upper respiratory tract infections, such as colds and sore throats.
* Mumps: This is a viral infection that causes swelling of the salivary glands, particularly in children.
* Measles: This is a highly contagious viral infection that causes fever, rash, and respiratory symptoms.
* Rubella (German measles): This is a viral infection that causes fever, rash, and mild respiratory symptoms.
Symptoms of paramyxovirus infections can vary depending on the specific virus causing the infection. However, common symptoms include:
* Fever
* Cough
* Runny nose
* Sore throat
* Headache
* Body aches
* Fatigue
* Swollen glands
* Rash (in the case of measles and rubella)
Diagnosis of paramyxovirus infections is typically made based on symptoms, physical examination, and laboratory tests such as PCR (polymerase chain reaction) or ELISA (enzyme-linked immunosorbent assay). Treatment is primarily focused on relieving symptoms and supporting the body's immune system. Antiviral medications may be prescribed in some cases, such as for severe measles infections.
Prevention of paramyxovirus infections includes vaccination against measles, mumps, and rubella (MMR vaccine), good hygiene practices such as handwashing and avoiding close contact with people who are sick, and avoiding sharing food and drinks.
Overall, paramyxovirus infections can be serious and potentially life-threatening, particularly in young children and immunocompromised individuals. However, with proper diagnosis, treatment, and prevention measures, the risk of complications and death can be significantly reduced.
Acute bronchitis is a short-term infection that is usually caused by a virus or bacteria, and can be treated with antibiotics and supportive care such as rest, hydration, and over-the-counter pain relievers. Chronic bronchitis, on the other hand, is a long-term condition that is often associated with smoking and can lead to chronic obstructive pulmonary disease (COPD).
Bronchitis can cause a range of symptoms including:
* Persistent cough, which may be dry or produce mucus
* Chest tightness or discomfort
* Shortness of breath or wheezing
* Fatigue and fever
* Headache and body aches
The diagnosis of bronchitis is usually made based on a physical examination, medical history, and results of diagnostic tests such as chest X-rays and pulmonary function tests. Treatment for bronchitis typically focuses on relieving symptoms and managing the underlying cause, such as a bacterial infection or smoking cessation.
Bronchitis can be caused by a variety of factors, including:
* Viral infections, such as the common cold or flu
* Bacterial infections, such as pneumonia
* Smoking and exposure to environmental pollutants
* Asthma and other allergic conditions
* Chronic lung diseases, such as COPD
Preventive measures for bronchitis include:
* Quitting smoking and avoiding exposure to secondhand smoke
* Getting vaccinated against flu and pneumonia
* Practicing good hygiene, such as washing hands frequently
* Avoiding exposure to environmental pollutants
* Managing underlying conditions such as asthma and allergies.
The common types of RTIs include:
1. Common cold: A viral infection that affects the upper respiratory tract, causing symptoms such as runny nose, sneezing, coughing, and mild fever.
2. Influenza (flu): A viral infection that can affect both the upper and lower respiratory tract, causing symptoms such as fever, cough, sore throat, and body aches.
3. Bronchitis: An inflammation of the bronchial tubes, which can be caused by viruses or bacteria, resulting in symptoms such as coughing, wheezing, and shortness of breath.
4. Pneumonia: An infection of the lungs that can be caused by bacteria, viruses, or fungi, leading to symptoms such as fever, chills, coughing, and difficulty breathing.
5. Tonsillitis: An inflammation of the tonsils, which can be caused by bacteria or viruses, resulting in symptoms such as sore throat, difficulty swallowing, and bad breath.
6. Sinusitis: An inflammation of the sinuses, which can be caused by viruses, bacteria, or fungi, leading to symptoms such as headache, facial pain, and nasal congestion.
7. Laryngitis: An inflammation of the larynx (voice box), which can be caused by viruses or bacteria, resulting in symptoms such as hoarseness, loss of voice, and difficulty speaking.
RTIs can be diagnosed through physical examination, medical history, and diagnostic tests such as chest X-rays, blood tests, and nasal swab cultures. Treatment for RTIs depends on the underlying cause and may include antibiotics, antiviral medications, and supportive care to manage symptoms.
It's important to note that RTIs can be contagious and can spread through contact with an infected person or by touching contaminated surfaces. Therefore, it's essential to practice good hygiene, such as washing hands frequently, covering the mouth and nose when coughing or sneezing, and avoiding close contact with people who are sick.
Some common types of lung diseases include:
1. Asthma: A chronic condition characterized by inflammation and narrowing of the airways, leading to wheezing, coughing, and shortness of breath.
2. Chronic Obstructive Pulmonary Disease (COPD): A progressive condition that causes chronic inflammation and damage to the airways and lungs, making it difficult to breathe.
3. Pneumonia: An infection of the lungs that can be caused by bacteria, viruses, or fungi, leading to fever, chills, coughing, and difficulty breathing.
4. Bronchiectasis: A condition where the airways are damaged and widened, leading to chronic infections and inflammation.
5. Pulmonary Fibrosis: A condition where the lungs become scarred and stiff, making it difficult to breathe.
6. Lung Cancer: A malignant tumor that develops in the lungs, often caused by smoking or exposure to carcinogens.
7. Cystic Fibrosis: A genetic disorder that affects the respiratory and digestive systems, leading to chronic infections and inflammation in the lungs.
8. Tuberculosis (TB): An infectious disease caused by Mycobacterium Tuberculosis, which primarily affects the lungs but can also affect other parts of the body.
9. Pulmonary Embolism: A blockage in one of the arteries in the lungs, often caused by a blood clot that has traveled from another part of the body.
10. Sarcoidosis: An inflammatory disease that affects various organs in the body, including the lungs, leading to the formation of granulomas and scarring.
These are just a few examples of conditions that can affect the lungs and respiratory system. It's important to note that many of these conditions can be treated with medication, therapy, or surgery, but early detection is key to successful treatment outcomes.
There are several possible causes of airway obstruction, including:
1. Asthma: Inflammation of the airways can cause them to narrow and become obstructed.
2. Chronic obstructive pulmonary disease (COPD): This is a progressive condition that damages the lungs and can lead to airway obstruction.
3. Bronchitis: Inflammation of the bronchial tubes (the airways that lead to the lungs) can cause them to narrow and become obstructed.
4. Pneumonia: Infection of the lungs can cause inflammation and narrowing of the airways.
5. Tumors: Cancerous tumors in the chest or throat can grow and block the airways.
6. Foreign objects: Objects such as food or toys can become lodged in the airways and cause obstruction.
7. Anaphylaxis: A severe allergic reaction can cause swelling of the airways and obstruct breathing.
8. Other conditions such as sleep apnea, cystic fibrosis, and vocal cord paralysis can also cause airway obstruction.
Symptoms of airway obstruction may include:
1. Difficulty breathing
2. Wheezing or stridor (a high-pitched sound when breathing in)
3. Chest tightness or pain
4. Coughing up mucus or phlegm
5. Shortness of breath
6. Blue lips or fingernail beds (in severe cases)
Treatment of airway obstruction depends on the underlying cause and may include medications such as bronchodilators, inhalers, and steroids, as well as surgery to remove blockages or repair damaged tissue. In severe cases, a tracheostomy (a tube inserted into the windpipe to help with breathing) may be necessary.
Examples of lung diseases, interstitial include:
1. Idiopathic pulmonary fibrosis (IPF): A chronic and progressive disease characterized by inflammation and scarring of the lungs without a known cause.
2. Sarcoidosis: A systemic disease characterized by inflammation and granulomas in various organs, including the lungs.
3. Hypersensitivity pneumonitis (HP): An immune-mediated reaction to inhaled antigens that can lead to inflammation and scarring of the lungs.
4. Pneumoconiosis: A group of lung diseases caused by inhaling dust, including asbestos, silica, and coal dust.
5. Desquamative interstitial pneumonitis (DIP): A rare disease characterized by progressive inflammation and scarring of the lungs.
6. Respiratory bronchiolitis-associated interstitial lung disease (RB-ILD): A rare disease caused by inflammation and scarring of the small airways and surrounding tissue.
7. Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF): A sudden worsening of IPF symptoms, often accompanied by inflammation and scarring of the lungs.
Symptoms of lung diseases, interstitial can include:
1. Shortness of breath (dyspnea)
2. Cough
3. Fatigue
4. Chest tightness or pain
5. Dry cough
6. Weight loss
7. Fever
Diagnosis is typically made through a combination of physical examination, medical history, laboratory tests (such as blood tests and lung function tests), and imaging studies (such as chest X-rays and computed tomography (CT) scans).
Treatment options for interstitial lung disease depend on the specific diagnosis and severity of the condition. These may include:
1. Medications to reduce inflammation and prevent further scarring, such as corticosteroids or immunosuppressants.
2. Oxygen therapy to help improve oxygen levels in the blood.
3. Pulmonary rehabilitation to improve lung function and overall health.
4. Surgical procedures, such as lung transplantation, in severe cases where other treatments have failed.
5. Lifestyle changes, such as quitting smoking and avoiding exposure to dust and pollutants.
The symptoms of mediastinal emphysema may include:
* Chest pain or tenderness
* Difficulty breathing
* Coughing up frothy sputum
* Fatigue
* Fevers
* Chills
If the emphysema is severe, it can lead to respiratory failure and other complications. Treatment options may include antibiotics for infection, oxygen therapy, and mechanical ventilation in severe cases. Surgery may be necessary in some instances to drain fluid or remove infected tissue.
Mediastinal emphysema can be diagnosed using imaging tests like chest X-rays, computed tomography (CT) scans, or magnetic resonance imaging (MRI). A mediastinoscopy, a procedure in which a flexible tube with a light and camera on the end is inserted through an incision in the neck to visualize the mediastinum, may also be performed to obtain a biopsy sample for further evaluation.
Overall, prompt diagnosis and treatment are essential to prevent complications and ensure proper management of mediastinal emphysema.
Types of Adenoviridae Infections:
1. Respiratory adenovirus infection (bronchiolitis, pneumonia)
2. Gastroenteric adenovirus infection (gastroenteritis)
3. Eye adenovirus infection (conjunctivitis)
4. Skin adenovirus infection (keratoconjunctivitis)
5. Intestinal adenovirus infection (diarrhea, vomiting)
6. Adenovirus-associated hemorrhagic cystitis
7. Adenovirus-associated hypertrophic cardiomyopathy
8. Adenovirus-associated myocarditis
Symptoms of Adenoviridae Infections:
1. Respiratory symptoms (cough, fever, difficulty breathing)
2. Gastrointestinal symptoms (diarrhea, vomiting, abdominal pain)
3. Eye symptoms (redness, discharge, sensitivity to light)
4. Skin symptoms (rash, blisters, skin erosion)
5. Intestinal symptoms (abdominal cramps, fever, chills)
6. Cardiovascular symptoms (hypertension, tachycardia, myocarditis)
Diagnosis of Adenoviridae Infections:
1. Physical examination and medical history
2. Laboratory tests (rapid antigen detection, PCR, electron microscopy)
3. Imaging studies (chest X-ray, CT scan, MRI)
4. Biopsy (tissue or organ biopsy)
Treatment of Adenoviridae Infections:
1. Supportive care (fluids, oxygen therapy, pain management)
2. Antiviral medications (ribavirin, cidofovir)
3. Immune modulators (immunoglobulins, corticosteroids)
4. Surgical intervention (in severe cases of adenovirus-associated disease)
Prevention of Adenoviridae Infections:
1. Good hygiene practices (handwashing, surface cleaning)
2. Avoiding close contact with individuals who are infected
3. Properly storing and preparing food
4. Avoiding sharing of personal items (utensils, drinking glasses, towels)
5. Immunization (vaccination against adenovirus)
Incubation Period:
The incubation period for adenoviruses is typically between 3-7 days, but it can range from 1-2 weeks in some cases.
Contagious Period:
Adenoviruses are highly contagious and can be transmitted before symptoms appear and during the entire course of illness. The virus can be shed for several weeks after infection.
Risk Factors:
Individuals with weakened immune systems (children, elderly, those with chronic illnesses) are at a higher risk of developing severe adenovirus infections. Additionally, those who live in crowded or unsanitary conditions and those who engage in behaviors that compromise their immune system (smoking, excessive alcohol consumption) are also at a higher risk.
Complications:
Adenovirus infections can lead to a variety of complications, including pneumonia, meningitis, encephalitis, and other respiratory, gastrointestinal, and eye infections. In severe cases, adenovirus infections can be fatal.
Recovery Time:
The recovery time for adenovirus infections varies depending on the severity of the infection and the individual's overall health. Mild cases of adenovirus may resolve within a few days to a week, while more severe cases may take several weeks to recover from. In some cases, hospitalization may be necessary for individuals with severe infections or those who experience complications.
Contraception:
There is no specific contraceptive measure that can prevent adenovirus infections. However, practicing good hygiene, such as frequent handwashing and avoiding close contact with people who are sick, can help reduce the risk of transmission.
Pregnancy:
Adenovirus infections during pregnancy are rare but can be severe. Pregnant women who develop adenovirus infections may experience complications such as preterm labor and low birth weight. It is essential for pregnant women to seek medical attention immediately if they suspect they have an adenovirus infection.
Diagnosis:
Adenovirus infections can be diagnosed through a variety of tests, including polymerase chain reaction (PCR), electron microscopy, and culture. A healthcare provider will typically perform a physical examination and take a medical history to determine the likelihood of an adenovirus infection.
Treatment:
There is no specific treatment for adenovirus infections, but symptoms can be managed with supportive care such as hydration, rest, and over-the-counter pain relievers. Antiviral medications may be prescribed in severe cases or for individuals with compromised immune systems.
Prevention:
Preventing the spread of adenovirus is essential, especially in high-risk populations such as young children and those with weakened immune systems. Practicing good hygiene, such as frequent handwashing and avoiding close contact with people who are sick, can help reduce the risk of transmission. Vaccines are also available for some types of adenovirus.
Prognosis:
The prognosis for adenovirus infections is generally good, especially for mild cases. However, severe cases can lead to complications such as pneumonia, meningitis, and encephalitis, which can be life-threatening. In some cases, long-term health problems may persist after recovery from an adenovirus infection.
Complications:
Adenovirus infections can lead to various complications, including:
1. Pneumonia: Adenovirus can cause pneumonia, which is an inflammation of the lungs that can lead to fever, chest pain, and difficulty breathing.
2. Meningitis: Adenovirus can cause meningitis, which is an inflammation of the membranes surrounding the brain and spinal cord. Symptoms include headache, stiff neck, and sensitivity to light.
3. Encephalitis: Adenovirus can cause encephalitis, which is an inflammation of the brain that can lead to confusion, seizures, and coma.
4. Gastrointestinal symptoms: Adenovirus can cause gastrointestinal symptoms such as diarrhea, vomiting, and abdominal pain.
5. Long-term health problems: In some cases, adenovirus infections can lead to long-term health problems such as asthma, allergies, and autoimmune disorders.
Asthma can cause recurring episodes of wheezing, coughing, chest tightness, and shortness of breath. These symptoms occur when the muscles surrounding the airways contract, causing the airways to narrow and swell. This can be triggered by exposure to environmental allergens or irritants such as pollen, dust mites, pet dander, or respiratory infections.
There is no cure for asthma, but it can be managed with medication and lifestyle changes. Treatment typically includes inhaled corticosteroids to reduce inflammation, bronchodilators to open up the airways, and rescue medications to relieve symptoms during an asthma attack.
Asthma is a common condition that affects people of all ages, but it is most commonly diagnosed in children. According to the American Lung Association, more than 25 million Americans have asthma, and it is the third leading cause of hospitalization for children under the age of 18.
While there is no cure for asthma, early diagnosis and proper treatment can help manage symptoms and improve quality of life for those affected by the condition.
Symptoms of pneumonia may include cough, fever, chills, difficulty breathing, and chest pain. In severe cases, pneumonia can lead to respiratory failure, sepsis, and even death.
There are several types of pneumonia, including:
1. Community-acquired pneumonia (CAP): This type of pneumonia is caused by bacteria or viruses and typically affects healthy people outside of hospitals.
2. Hospital-acquired pneumonia (HAP): This type of pneumonia is caused by bacteria or fungi and typically affects people who are hospitalized for other illnesses or injuries.
3. Aspiration pneumonia: This type of pneumonia is caused by food, liquids, or other foreign matter being inhaled into the lungs.
4. Pneumocystis pneumonia (PCP): This type of pneumonia is caused by a fungus and typically affects people with weakened immune systems, such as those with HIV/AIDS.
5. Viral pneumonia: This type of pneumonia is caused by viruses and can be more common in children and young adults.
Pneumonia is typically diagnosed through a combination of physical examination, medical history, and diagnostic tests such as chest X-rays or blood tests. Treatment may involve antibiotics, oxygen therapy, and supportive care to manage symptoms and help the patient recover. In severe cases, hospitalization may be necessary to provide more intensive care and monitoring.
Prevention of pneumonia includes vaccination against certain types of bacteria and viruses, good hygiene practices such as frequent handwashing, and avoiding close contact with people who are sick. Early detection and treatment can help reduce the risk of complications and improve outcomes for those affected by pneumonia.
There are several types of pulmonary fibrosis, including:
1. Idiopathic pulmonary fibrosis (IPF): This is the most common and severe form of the disease, with no known cause or risk factors. It is characterized by a rapid decline in lung function and poor prognosis.
2. Connective tissue disease-associated pulmonary fibrosis: This type is associated with conditions such as rheumatoid arthritis, systemic lupus erythematosus, and scleroderma.
3. Drug-induced pulmonary fibrosis: Certain medications, such as amiodarone and nitrofurantoin, can cause lung damage and scarring.
4. Radiation-induced pulmonary fibrosis: Exposure to high doses of radiation, especially in childhood, can increase the risk of developing pulmonary fibrosis later in life.
5. Environmental exposures: Exposure to pollutants such as silica, asbestos, and coal dust can increase the risk of developing pulmonary fibrosis.
Symptoms of pulmonary fibrosis include shortness of breath, coughing, and fatigue. The disease can be diagnosed through a combination of imaging tests such as chest X-rays, computed tomography (CT) scans, and magnetic resonance imaging (MRI), as well as lung biopsy.
Treatment options for pulmonary fibrosis are limited and vary depending on the underlying cause of the disease. Medications such as pirfenidone and nintedanib can help slow the progression of the disease, while lung transplantation may be an option for advanced cases.
Bronchiolitis
Bronchiolitis obliterans
Necrotizing bronchiolitis
Respiratory bronchiolitis
Occupational lung disease
Equid alphaherpesvirus 4
Idiopathic interstitial pneumonia
Reactive airway disease
Epinephrine (medication)
Gary R. Epler
High-resolution computed tomography
Adrenaline
Trachea
Antibiotic misuse
Bagassosis
Cadherin related family member 3
Diffuse panbronchiolitis
Activated charcoal (medication)
Activated carbon
Broad-spectrum chemokine inhibitor
NR58-3.14.3
Papaverine
Paramyxoviridae
Unnecessary health care
Tumebacillus
Safety of electronic cigarettes
Alicyclobacillaceae
Swyer-James syndrome
Fifth disease
History of coronavirus
Obliterative Bronchiolitis in Workers in a Coffee-Processing Facility - Texas, 2008-2012
Bronchiolitis: MedlinePlus Medical Encyclopedia
Bronchiolitis Obliterans Organizing Pneumonia (BOOP) Imaging: Practice Essentials, Radiography, Computed Tomography
Bronchiolitis Information | Mount Sinai - New York
Enteral feeding is safe during bronchiolitis HFNC - The Hospitalist
Human Metapneumovirus in Severe Respiratory Syncytial Virus Bronchiolitis - Volume 9, Number 3-March 2003 - Emerging Infectious...
Use of high flow nasal cannula oxygen (HFNCO) in infants with bronchiolitis on a paediatric ward: a 3-year experience |...
Human Parainfluenza Viruses (HPIV) and Other Parainfluenza Viruses Clinical Presentation: History, Physical Examination,...
Long-term effects of prednisolone in the acute phase of bronchiolitis caused by respiratory syncytial virus<...
Bronchiolitis :: Healthier Together
Human Parainfluenza Viruses (HPIV) and Other Parainfluenza Viruses Clinical Presentation: History, Physical Examination,...
Bronchiolitis Treatment | Gainesville, GA
Bronchiolitis - Symptoms & Causes | Gleneagles Hospital
Specialists acute bronchiolitis Seoul ※TOP 10※
Bronchiolitis and RSV :: West Yorkshire Healthier Together
Respiratory system diseases | Health and medicine | Science | Khan Academy
Viral bronchiolitis management in hospitals in the UK - Immunology
Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. | Cochrane Database Syst Rev;...
Antibiotics for bronchiolitis in children - Fingerprint - Bond University Research Portal
CTDetailNew
Diagnosis of bronchiolitis obliterans organizing pneumonia after allogeneic bone marrow transplantation : case report -...
Beryllium Toxicity: How Does Beryllium Induce Pathogenic Changes? | Environmental Medicine | ATSDR
Dr. Vincent Lem, MD - Pulmonology Specialist in Kansas City, MO | Healthgrades
Pneumonia10
- When organizing pneumonia is associated with granulation tissue in the bronchiolar lumen, the qualifying term bronchiolitis obliterans (BO) is added. (medscape.com)
- Cryptogenic organizing pneumonia (COP) is often confused with bronchiolitis obliterans organizing pneumonia (BOOP). (medscape.com)
- Bronchiolitis obliterans organizing pneumonia is an inflammatory reaction with a variety of causes. (medscape.com)
- Transbronchial lung biopsy confirmed the diagnosis of bronchiolitis obliterans organizing pneumonia. (medscape.com)
- Human parainfluenza viruses (HPIVs) have been associated with every type of upper and lower respiratory tract illness, including common cold with fever, laryngotracheobronchitis (croup), bronchiolitis , and pneumonia . (medscape.com)
- HPIV-1 and HPIV-2 are the pathogens most commonly associated with croup, and HPIV-3 is the pathogen most commonly associated with bronchiolitis and pneumonia in infants and young children. (medscape.com)
- HPIV infections can also present as bronchiolitis or pneumonia. (medscape.com)
- HPIV-1 and HPIV-3 each cause about 10% of outpatient pneumonia cases, but as with bronchiolitis, HPIV-3 causes a larger percentage of cases in hospitalized patients. (medscape.com)
- Severe complications include pneumonia and bronchiolitis. (cdc.gov)
- RSV is the most common cause of bronchiolitis and pneumonia in children under one year of age in the United States. (cdc.gov)
Contracted bronchiolitis obliterans1
- If you are an adult who has contracted bronchiolitis obliterans, unfortunately there is no cure. (pediatric-centers.com)
Acute13
- During the acute infection the immune response may induce long-lasting detrimental effects, thereby contributing to post-bronchiolitis wheezing (PBW). (edu.au)
- Therefore, immune-modulating drugs like corticosteroids, administered in the acute phase of RSV bronchiolitis, may prevent PBW and asthma. (edu.au)
- We conclude that oral prednisolone during the acute phase of RSV bronchiolitis is not effective in preventing PBW or asthma at the mean age of 5 years. (edu.au)
- 5 You will appear in the first positions of Google as the best in Specialists acute bronchiolitis. (forseoulovers.com)
- Chest physiotherapy for acute bronchiolitis in paediatric patients between 0 and 24 months old. (bvsalud.org)
- Acute bronchiolitis is the leading cause of medical emergencies during winter in children younger than two years of age. (bvsalud.org)
- The main objective was to determine the efficacy of chest physiotherapy in infants aged less than 24 months old with acute bronchiolitis . (bvsalud.org)
- Chest physiotherapy does not improve the severity of the disease , respiratory parameters , or reduce length of hospital stay or oxygen requirements in hospitalised infants with acute bronchiolitis not on mechanical ventilation . (bvsalud.org)
- Background: Acute lower respiratory tract infection (LRTI) including bronchiolitis, is one of the leading causes of pediatric hospital admissions worldwide. (edu.au)
- Recent studies have demonstrated that some children with acute bronchiolitis can be successfully managed using home oxygen therapy. (edu.au)
- Aim: To report the impact of a Hospital in The Home Oxygen therapy program (HiTHOx) for selected infants and young children with acute bronchiolitis and other LRTI. (edu.au)
- Findings: The HiTHOx program appears to be a safe model of care for carefully selected infants and young children with acute bronchiolitis and LRTI that reduces the hospital length of stay. (edu.au)
- In acute disease, high levels of beryllium exposure can result in inflammation of the upper and lower respiratory tract and airways, bronchiolitis, pulmonary edema, and chemical pneumonitis. (cdc.gov)
High flow nasal cannula1
- SEATTLE - There were no cases of aspiration with enteric feeds of 60 children aged up to 2 years on high flow nasal cannula (HFNC) for bronchiolitis at the University of Oklahoma Children's Hospital, Oklahoma City, according to research presented at the 2019 Pediatric Hospital Medicine Conference. (the-hospitalist.org)
Obliterative bronchiolitis6
- This report describes two cases of obliterative bronchiolitis identified in workers employed in a small coffee-processing facility. (cdc.gov)
- Both patients' illness was misdiagnosed before they received a diagnosis of work-related obliterative bronchiolitis, which had not been identified previously in the coffee-processing industry. (cdc.gov)
- If obliterative bronchiolitis is suspected, immediate protection from further exposure is crucial to prevent further deterioration of lung function. (cdc.gov)
- an open lung biopsy was performed, which revealed constrictive bronchiolitis (the histopathologic correlate of obliterative bronchiolitis) with both narrowed and obliterated airways with surrounding fibrous tissue and a variable mixed chronic inflammatory cell infiltrate. (cdc.gov)
- Based on this result, she received a diagnosis of obliterative bronchiolitis. (cdc.gov)
- Background: Asthma and obliterative bronchiolitis (OB) cases have occurred among styrene-exposed workers. (cdc.gov)
Pulmonary edema2
Respiratory syncy3
- Reverse transcription-polymerase chain reaction was used to detect segments of the M (matrix), N (nucleoprotein), and F (fusion) genes of human metapneumovirus in bronchoalveolar fluid from 30 infants with severe respiratory syncytial virus bronchiolitis. (cdc.gov)
- Follow-up studies have demonstrated that bronchiolitis caused by respiratory syncytial virus (RSV) is strongly associated with wheezing in the ensuing years. (edu.au)
- The most common cause of bronchiolitis is due to a viral infection and is usually caused by the respiratory syncytial virus (RSV), with common outbreaks occurring in winter months and affecting children under the age of 1. (pediatric-centers.com)
Infants and young children1
- Bronchiolitis is a common viral chest infection that occurs in infants and young children. (gleneagles.com.sg)
Hospitalization1
- For severe cases of bronchiolitis, hospitalization may be required to receive humidified oxygen in order to maintain sufficient oxygen in the blood or fluids through a vein (intravenously) to prevent dehydration. (pediatric-centers.com)
Airways2
- Bronchiolitis is an inflammation of the bronchioles (smaller airways that branch off the main airway) usually caused by a viral infection. (mountsinai.org)
- Bronchiolitis is a common viral infection in young children and infants, causing inflammation and congestion of the small airways in the lungs (bronchioles). (pediatric-centers.com)
Infection3
- Bronchiolitis begins as a mild upper respiratory infection. (medlineplus.gov)
- Most cases of bronchiolitis cannot be prevented because the viruses that cause the infection are common in the environment. (medlineplus.gov)
- Antibiotics are not typically helpful in treating bronchiolitis as the infection is viral. (pediatric-centers.com)
Symptoms4
- Most of the time, bronchiolitis can be diagnosed based on the symptoms and the exam. (medlineplus.gov)
- Bronchiolitis symptoms in children and adults warrant medical intervention. (pediatric-centers.com)
- Additional bronchiolitis symptoms which warrant prompt medical treatment include vomiting, fast or labored breathing or a bluish appearance in the skin (especially in the lips and fingernails). (pediatric-centers.com)
- What are the symptoms of bronchiolitis? (gleneagles.com.sg)
Wheezing1
- Wheezing, bronchiolitis, and bronchitis. (medlineplus.gov)
20001
- As part of a larger study examining the immunopathogenesis of severe bronchiolitis, nonbronchoscopic bronchoalveolar lavage samples were collected from 30 infants ventilated with RSV bronchiolitis (determined by antigen detection in nasopharyngeal aspirates) in 2000 and 2001. (cdc.gov)
Bronchitis1
- Bronchiolitis, presenting breathing difficulty in children whose immune systems are delicate, is considered to be more serious of an illness than bronchitis is for adults. (pediatric-centers.com)
Airway1
- Previously, we have demonstrated that cGVHD induced by allogeneic HSCT after a conditioning regimen of cyclophosphamide and total-body radiation results in pulmonary dysfunction and airway obliteration, which leads to bronchiolitis obliterans (BO), which is pathognomonic for cGVHD of the lung. (umn.edu)
Peaks2
- The incidence of bronchiolitis peaks during the first year of life (with 81% of cases occurring during this period) and then declines dramatically until it virtually disappears by school age. (medscape.com)
- The number of children with RSV usually peaks in winter but bronchiolitis can happen at any time of year. (wyhealthiertogether.nhs.uk)
Mild1
- Bronchiolitis is usually mild and treatment is largely supportive eg. (cgh.com.sg)
Treatments1
- There are no medical treatments that speed up recovery from bronchiolitis. (wyhealthiertogether.nhs.uk)
Severity1
- Such coinfection might be a factor influencing the severity of bronchiolitis. (cdc.gov)
Cases3
- All 5 serotypes of HPIV can cause bronchiolitis, but the ones most commonly associated with this condition are HPIV-1 and HPIV-3, each of which appears to cause 10-15% of bronchiolitis cases in nonhospitalized children. (medscape.com)
- In rare cases, bronchiolitis may also be caused by bacteria. (gleneagles.com.sg)
- We identified three cases consistent with bronchiolitis obliterans syndrome with air trapping on high-resolution computed tomography of the lungs, in the highest exposure group of 102 process operators. (occupationalasthma.com)
Cigarette smoke1
- Infants exposed to cigarette smoke are at increased risk of bronchiolitis. (gleneagles.com.sg)
Management1
- Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis. (medlineplus.gov)
Illness1
- Bronchiolitis is an important cause of illness and death in infants. (cdc.gov)
Patients2
- Fifty-four patients under 2 years of age and hospitalized for RSV bronchiolitis between 1992 and 1995 were randomly assigned to prednisolone 1 mg/kg/day for 7 days or placebo. (edu.au)
- SELECTION CRITERIA Randomised controlled trials (RCTs) in which chest physiotherapy was compared against no intervention or against another type of physiotherapy in bronchiolitis patients younger than 24 months of age. (bvsalud.org)
Immune1
- Infants aged 3 months are at the greatest risk for bronchiolitis due to their lungs and immune systems not being fully developed. (pediatric-centers.com)
Occurs1
- Bronchiolitis occurs more often in the fall and winter than other times of the year. (medlineplus.gov)
Child1
- Viral testing in which your healthcare provider collects a sample of mucus (taken with a cotton swab that is inserted into the nose) from your child to inspect for the virus causing bronchiolitis. (pediatric-centers.com)
Risk3
- What are the risk factors for bronchiolitis? (gleneagles.com.sg)
- Rationale: Workers in microwave popcorn plants are at risk of developing bronchiolitis obliterans associated with exposure to butter flavoring volatiles, including diacetyl. (occupationalasthma.com)
- Objectives: To investigate the risk of bronchiolitis obliterans for chemical workers producing diacetyl, with exposure to less complex mixtures of chemicals. (occupationalasthma.com)
Supportive1
- Most children diagnosed with bronchiolitis can be treated at home with supportive care. (pediatric-centers.com)
Treatment2
- To schedule a consultation with a qualified healthcare provider in Gainesville that specializes in bronchiolitis treatment , call (770) 674-6311 or contact Natural Medical Solutions Wellness Center online . (pediatric-centers.com)
- Schedule a consultation with a qualified healthcare provider in Gainesville that specializes in bronchiolitis treatment . (pediatric-centers.com)
Children under the age1
- Bronchiolitis affects children under the age of 2. (wyhealthiertogether.nhs.uk)